Highland Capital Management (Texas)’s Aratana Therapeutics, Inc. PETX Stock Holding History

Highland Capital Management (Texas)’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$197K	Buy	+38,180	New	+$172K	0.01%	300
2015 Q1	–	Sell	-212,888	Closed	-$3.79M	–	265
2014 Q4	$3.79M	Sell	212,888 -446,066	-68%	-$5.56M	0.13%	115
2014 Q3	$6.62M	Buy	+658,954	New	+$7.99M	0.25%	95
2014 Q2	–	Sell	-229,004	Closed	-$4.25M	–	318
2014 Q1	$4.25M	Buy	+229,004	New	+$4.59M	0.17%	99

Other funds holding PETX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Highland Capital Management (Texas)'s PETX Position: Q2 2019 in Review

Highland Capital Management (Texas) opened a new position in Aratana Therapeutics, Inc. (PETX) in Q2 2019: 38,180 shares worth $197K. The stake represents 0.01% of the portfolio and ranks #300 among its holdings. This is a return to the name: Highland Capital Management (Texas) previously reported a position in PETX as recently as Q4 2014.

Highland Capital Management (Texas) first reported a position in PETX in Q1 2014 and has held it in 4 quarters since. The position peaked at $6.62M in Q3 2014. 103 funds tracked by Wall St. Rank hold PETX as of Q2 2019.

Highland Capital Management (Texas) held 38,180 shares of Aratana Therapeutics, Inc. worth $197K as of Q2 2019.
Aratana Therapeutics, Inc. was a new Highland Capital Management (Texas) position in Q2 2019.
Aratana Therapeutics, Inc. made up 0.01% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #300 holding.
Highland Capital Management (Texas) first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and has held it in 4 quarters since.
Highland Capital Management (Texas)'s Aratana Therapeutics, Inc. position peaked at $6.62M in Q3 2014.
103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.